BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 18957876)

  • 1. Effects of ubiquinone (coenzyme Q10) on myopathy in statin users.
    Schaars CF; Stalenhoef AF
    Curr Opin Lipidol; 2008 Dec; 19(6):553-7. PubMed ID: 18957876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations for supplementing with coenzyme Q10 during statin therapy.
    Levy HB; Kohlhaas HK
    Ann Pharmacother; 2006 Feb; 40(2):290-4. PubMed ID: 16449543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG-CoA reductase inhibitors and coenzyme Q10.
    Nawarskas JJ
    Cardiol Rev; 2005; 13(2):76-9. PubMed ID: 15705257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.
    Harper CR; Jacobson TA
    Curr Opin Lipidol; 2007 Aug; 18(4):401-8. PubMed ID: 17620856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coenzyme Q10 and statins: biochemical and clinical implications.
    Littarru GP; Langsjoen P
    Mitochondrion; 2007 Jun; 7 Suppl():S168-74. PubMed ID: 17482884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin myopathy: an update.
    Christopher-Stine L
    Curr Opin Rheumatol; 2006 Nov; 18(6):647-53. PubMed ID: 17053514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Statin drugs decrease the plasma level of coenzyme Q10 (ubiquinone) in the organism].
    Rákóczi K; Párdutz A; Vécsei L
    Ideggyogy Sz; 2007 Jul; 60(7-8):295-300. PubMed ID: 17713110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coenzyme Q10 in patients undergoing CABG: Effect of statins and nutritional supplementation.
    Keith M; Mazer CD; Mikhail P; Jeejeebhoy F; Briet F; Errett L
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):105-11. PubMed ID: 17368873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of coenzyme Q10 in statin-associated myopathy: a systematic review.
    Marcoff L; Thompson PD
    J Am Coll Cardiol; 2007 Jun; 49(23):2231-7. PubMed ID: 17560286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of coenzyme q10 on myopathic symptoms in patients treated with statins.
    Caso G; Kelly P; McNurlan MA; Lawson WE
    Am J Cardiol; 2007 May; 99(10):1409-12. PubMed ID: 17493470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low myopathy rates associated with statins as monotherapy or combination therapy with interacting drugs in a group model health maintenance organization.
    Shanahan RL; Kerzee JA; Sandhoff BG; Carroll NM; Merenich JA
    Pharmacotherapy; 2005 Mar; 25(3):345-51. PubMed ID: 15843281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coenzyme Q10 depletion: etiopathogenic or predisposing factor in statin associated myopathy?
    Chatzizisis YS; Vaklavas C; Giannoglou GD
    Am J Cardiol; 2008 Apr; 101(7):1071. PubMed ID: 18359340
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced mitochondrial coenzyme Q10 levels in HepG2 cells treated with high-dose simvastatin: a possible role in statin-induced hepatotoxicity?
    Tavintharan S; Ong CN; Jeyaseelan K; Sivakumar M; Lim SC; Sum CF
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):173-9. PubMed ID: 17610923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coenzyme Q10 in statin-associated myopathy.
    Wolinsky H
    J Am Coll Cardiol; 2007 Nov; 50(19):1911; author reply 1911. PubMed ID: 17980261
    [No Abstract]   [Full Text] [Related]  

  • 15. Statin safety: lessons from new drug applications for marketed statins.
    Jacobson TA
    Am J Cardiol; 2006 Apr; 97(8A):44C-51C. PubMed ID: 16581328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia.
    Young JM; Florkowski CM; Molyneux SL; McEwan RG; Frampton CM; George PM; Scott RS
    Am J Cardiol; 2007 Nov; 100(9):1400-3. PubMed ID: 17950797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic predisposition to statin myopathy.
    Vladutiu GD
    Curr Opin Rheumatol; 2008 Nov; 20(6):648-55. PubMed ID: 18946323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characterization and molecular mechanisms of statin myopathy.
    Toth PP; Harper CR; Jacobson TA
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):955-69. PubMed ID: 18666846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin-induced myopathy: the two faces of Janus.
    Arora R; Liebo M; Maldonado F
    J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):105-12. PubMed ID: 16891287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins, cholesterol, Co-enzyme Q10, and Parkinson's disease.
    Lieberman A; Lyons K; Levine J; Myerburg R
    Parkinsonism Relat Disord; 2005 Mar; 11(2):81-4. PubMed ID: 15734664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.